Thank you. I have a couple of comments.
Actually, drug spending in Canada has not increased over the past number of years. That's primarily due to what was called the patent cliff. A number of large brand-name medicines lost patents a few years ago, and when the generics came on the market at 18% or 25%, that reduced costs.
The other thing about CETA is that I think the government actually acknowledged that there were going to be increased costs to the provinces and had agreed to fund those extra costs through extra transfer arrangements.